Similar articles

• Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.

  Agalliu I, Weiss NS, Lin DW, Stanford JL. Agalliu I, et al. Cancer Causes Control. 2007 Nov;18(9):931-7. doi: 10.1007/s10552-007-9031-7. Epub 2007 Jul 20. Cancer Causes Control. 2007. PMID: 17641982
• Screening for prostate cancer: recommendations and rationale.

  Berg AO; U.S. Preventive Services Task Force. Berg AO, et al. Am J Nurs. 2003 Mar;103(3):107-10; discussion 111. Am J Nurs. 2003. PMID: 12626949 No abstract available.
• Screening for prostate cancer: current recommendations.

  Wilson SS, Crawford ED. Wilson SS, et al. Urol Clin North Am. 2004 May;31(2):219-26. doi: 10.1016/j.ucl.2004.01.002. Urol Clin North Am. 2004. PMID: 15123402 Review.
• Screening decreases prostate cancer mortality: 11-year follow-up of the 1988 Quebec prospective randomized controlled trial.

  Labrie F, Candas B, Cusan L, Gomez JL, Bélanger A, Brousseau G, Chevrette E, Lévesque J. Labrie F, et al. Prostate. 2004 May 15;59(3):311-8. doi: 10.1002/pros.20017. Prostate. 2004. PMID: 15042607 Clinical Trial.
• Prostate cancer: enthusiasm for screening.

  Kaye KW. Kaye KW. Med J Aust. 1995 May 15;162(10):540-1. Med J Aust. 1995. PMID: 7539884 Review. No abstract available.